Accelerating Innovations: Addressing Heavy Menstrual Bleeding in Women in Low-Resource Settings
The Bill and
Melinda Gates Foundation is pleased to announce the Accelerating Innovations
Challenge to address Heavy Menstrual Bleeding in Women in Low-Resource
Settings.
The
Challenge
§ They invite research
proposals on HMB based on the clinical definition that focus on:
§ Biological Mechanisms – Advancing
understanding of the fundamental biology of HMB to identify targets for
innovative diagnostics and treatments.
§ Epidemiology and Impact – Assessing disease
burden, patterns, and impact on gynaecological health and quality of life
in women in low-resource
settings.
§ Measurement and
Standardization – Developing
and validating improved methods for measuring HMB and establishing standardized research protocols to enable consistent
and comparable studies across diverse populations and healthcare systems.
§ Innovative Diagnostics – Proposing new
technology or piloting the use of existing technology to identify causes of HMB
in low resource settings, including the use of artificial intelligence.
Technology should be easy to use and affordable.
§ Treatment and Access – Evaluating the
effectiveness, acceptability, and ways to increase access to treatment
including hormonal contraceptives, to inform patient-centered care in
low-resource settings.
Funding
Information
§ They will consider
proposals for awards of up to 150,000 USD for each project, with a grant term
of up to 2 years.
Eligibility
Criteria
§ This initiative is open to
nonprofit organizations, for-profit companies, international organizations,
government agencies and academic institutions. They particularly encourage
applications involving projects led by women or from women-led organizations
and applications from institutions based in low- and middle-income countries.
§ They seek proposals that:
§ Focus on original research
and development
§ Focus on the needs of women
in Sub-Saharan Africa, India, and Pakistan. While
researchers may be based globally, study populations (for original data
collection) or intended beneficiaries (for new diagnostics and treatments) must
be from these regions.
Ineligibility
Criteria
§ They will not fund
proposals that:
§ Do not focus on HMB – Even if related to
gynecological conditions that are associated with HMB, such as infertility or
pelvic pain.
§ Are not research. Proposals
to fund the expansion of routine services, or train clinical service providers,
for example, will not be funded.
For more information, visit Bill and Melinda Gates Foundation.